Sara Tolaney, MD, MPH, Dana-Farber Harvard Cancer Center
Advertisement
Articles by Sara Tolaney, MD, MPH, Dana-Farber Harvard Cancer Center
Advertisement
Latest Updated Articles
Perioperative Therapy: ASCO 2020 Data UpdatesAugust 13th 2020
Metastatic HR+ Breast Cancer UpdatesAugust 13th 2020
Metastatic Triple-Negative Breast Cancer Ongoing TrialsAugust 13th 2020
ASCO 2020 Data Updates: Metastatic HER2+ Breast CancerAugust 13th 2020
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Amivantamab and Hyaluronidase for Metastatic HNSCC
2
BCG Optimization Becomes a Priority as Durvalumab Gains a Role in High-Risk NMIBC
3
Dr Skoulidis on Divarasib vs Sotorasib or Adagrasib in KRAS G12C–Mutated NSCLC
4
Dr Cai on the Rationale for Evaluating Rocbrutinib Plus R-CHOP in Non-GCB DLBCL and MCL
5